Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsia
Teresa M. MacDonald, Stephen Tong, Jenny Myers, Ping Cannon, Tuong-Vi Nguyen, Emerson Keenan, Elizabeth Murray, Alesia Harper, Natasha Pritchard, Natalie J. Hannan, Kirsten M. Dane, Anna L. Middleton, Valerie Kyritsis, Susan Walker, Tu’uhevaha J. Kaitu’u‐Lino
Topics & Concepts
PreeclampsiaMedicineTissue factor pathway inhibitorPlacental growth factorBiomarkerInternal medicineGestationPlacentaCase-control studyTissue factorEndocrinologyPregnancyObstetricsFetusCoagulationVascular endothelial growth factorBiologyVEGF receptorsGeneticsBiochemistryPregnancy and preeclampsia studiesMaternal and fetal healthcareBlood Coagulation and Thrombosis Mechanisms